Ablative Solutions - Gilde Healthcare

Ablative Solutions

San Jose (CA), USA
Since: 2019

US-based MedTech focused on treatment of hypertension via renal denervation.

Ablative Solutions is a medical device company that has developed a best-in-class drug delivery catheter, the Peregrine SystemTM, which delivers a neurolytic agent to the adventitia of the renal arteries for the purposes of ablating the surrounding nerves.

This procedure, known as renal denervation, has a potentially significant effect in the treatment of hypertension.

The Ablative Solutions procedure is quick, relatively painless and results in deep, circumferential ablation of the renal nerves.

The company has CE Mark and is currently engaged in clinical studies in Europe and the United States.

More Ablative Solutions news

Gilde Healthcare company Ablative Solutions demonstrates Significant Reduction in Blood Pressure meeting its primary endpoint in Pivotal Trial

Gilde Healthcare’s Ablative Solutions, Inc. meets Primary Endpoint in Pivotal Trial for Hypertension

Ablative Solutions Announces Publication of Data from the Peregrine Post-Market Study in the Journal of the American College of Cardiology: Cardiovascular Interventions

Ablative Solutions Announces Positive 12-Month Results from Study Evaluating Company’s Novel Therapy for Uncontrolled Hypertension

Ablative Solutions Announces Appointment of Kate Rumrill as President and Chief Executive Officer